Hivus-LR 200 mg/50 mg Lopinavir/Ritonavir Tablets (1 pack / 60 tabs)

At a Glance

Generic Name: Lopinavir + Ritonavir

Brand Name: Hivus-LR

Strength & Pack Size: 200 mg/50 mg per tablet; 1 pack / 60 tablets

Dosage Form & Route: Oral tablet, swallowed whole with water

Therapeutic Class: Boosted protease inhibitor (PI) combination for antiretroviral therapy (ART)

Primary Indication: HIV-1 infection as part of a complete combination ART regimen

Typical Use in Therapy: Used within specialist-managed ART plans; regimen choice depends on resistance, interactions, and tolerability

Prescription Status: Prescription-only medicine

Storage: Store in original packaging as directed on the label; protect from moisture and keep out of reach of children

Product Description

Hivus-LR contains lopinavir/ritonavir, a fixed-dose antiretroviral combination used for HIV-1 treatment when prescribed as part of a complete ART regimen. Each tablet combines lopinavir (the active protease inhibitor) with ritonavir (a pharmacokinetic booster), and this pack provides 1 pack / 60 tablets for planned use within a prescription-led HIV care plan. Patients and caregivers managing a prescription-led ART plan often search for this treatment as generic Hivus-LR online. As with all HIV medicines, selection and monitoring should remain under the supervision of a qualified HIV clinician.

Lopinavir/ritonavir is widely recognized as a boosted protease inhibitor approach in antiretroviral therapy. Treatment decisions depend on prior ART exposure, resistance patterns where known, coexisting conditions, and clinically important drug–drug interactions. In some care pathways, patients also compare generic Kaletra options, since Hivus-LR is commonly positioned as a generic alternative to the originator product. Because protease inhibitor–based regimens can involve interaction management and laboratory monitoring, therapy should never be started, stopped, or adjusted without specialist guidance.

Generic Meds Mart supplies Generic Hivus-LR 200/50 mg lopinavir/ritonavir tablets in original packaging sourced through licensed channels. The pack typically displays product name (Hivus-LR), strength, active ingredients, batch number, and expiry date to support verification by clinics and pharmacies. Orders are shipped in discreet outer packaging to support privacy, with global delivery options designed for structured access and logistics rather than clinical decision-making. If you are comparing packs or planning refills, confirm the correct strength and pack size with your HIV specialist before ordering and avoid decisions based only on lopinavir/ritonavir price.

Key Uses

Hivus-LR (lopinavir/ritonavir) is used for HIV-1 infection as part of combination antiretroviral therapy (ART) under specialist supervision. It is generally considered within boosted protease inhibitor strategies, where ritonavir is used to increase lopinavir exposure and support consistent antiviral activity when taken exactly as prescribed. Your clinician defines whether a PI-based regimen is appropriate based on your treatment history, interaction risks, and monitoring plan.

Common Searches and Treatment Contexts for Lopinavir/Ritonavir

• Generic Kaletra (Lopinavir/Ritonavir): Hivus-LR is commonly referenced as a generic Kaletra option because it contains the same active ingredients at the same strength, used for HIV therapy within a complete ART regimen.
• Boosted Protease Inhibitor Regimen: Ritonavir boosts lopinavir levels, supporting a PI-based ART approach where dosing consistency and interaction management are essential.
• Fixed-Dose Combination HIV Tablet: Lopinavir and ritonavir are combined in one tablet to simplify administration compared with separate components in some older protocols.
• HIV Medication Planning and Refills: Patients and clinics may search lopinavir ritonavir tablets online to coordinate ongoing ART supply with follow-up visits and routine monitoring.

How Lopinavir/Ritonavir Works in HIV Treatment

Lopinavir inhibits the HIV protease enzyme, which the virus needs to process proteins and produce mature infectious viral particles. By blocking protease activity, lopinavir reduces the production of functional virus and supports viral load suppression when used as part of combination antiretroviral therapy. Ritonavir is included primarily as a booster: it inhibits metabolic pathways that break down lopinavir, increasing lopinavir concentrations and helping maintain effective exposure across the dosing interval.

Because boosting changes drug levels, lopinavir/ritonavir therapy requires careful attention to interactions with other prescriptions, over-the-counter medicines, and supplements. HIV specialists consider these factors when designing a regimen and deciding which companion antiretrovirals are used alongside boosted protease inhibitors. Treatment response is evaluated through routine clinical follow-up and laboratory monitoring as determined by your care team.

Dosage & Administration

Hivus-LR must be taken exactly as prescribed by an HIV clinician within a complete ART regimen. The correct schedule, duration, and any dose adjustments depend on your individual plan, treatment history, and interacting medicines. For questions about lopinavir/ritonavir dosage, follow your specialist’s instructions and the approved product information rather than relying on informal dosing advice.

Swallow tablets whole with water, and do not change timing, split doses, or stop treatment without medical guidance. If you take other medicines, especially those with known interaction potential, share a complete list with your prescriber and pharmacist so your regimen can be managed safely. If a dose is missed, your clinic can advise the safest next step based on your schedule and the overall ART plan.

Precautions

Drug–drug interactions are a key precaution with lopinavir/ritonavir. Some medicines can raise or lower antiretroviral levels, increasing the risk of side effects or reducing antiviral efficacy. Your specialist may review cardiac risk factors, liver health, and metabolic parameters when selecting a boosted protease inhibitor regimen. Report new symptoms promptly, especially persistent gastrointestinal upset, unusual fatigue, palpitations, fainting, or signs of allergic reactions.

Laboratory monitoring may include liver tests, lipid levels, glucose, and other parameters based on your individual risk profile. HIV treatment should remain coordinated through a qualified clinician, and substitutions between products should be confirmed rather than assumed. Pregnancy, breastfeeding, and pediatric use require specialist oversight and should follow local guidance and approved prescribing information.

Lopinavir/Ritonavir Side Effects

Common side effects

Common lopinavir/ritonavir side effects can include diarrhea, nausea, abdominal discomfort, headache, fatigue, and changes in laboratory values such as lipids or liver enzymes. Some people experience appetite changes or sleep disturbance. Many effects are manageable within specialist-led HIV care, but persistent symptoms should be discussed with your clinic so supportive measures or regimen review can be considered.

Serious side effects

Serious adverse effects may include significant liver problems, severe allergic reactions, pancreatitis, clinically important heart rhythm disturbances, or severe metabolic changes. Seek urgent medical care if you experience severe abdominal pain, yellowing of the skin or eyes, dark urine, severe rash, chest pain, fainting, or rapidly worsening symptoms. Any major symptom changes during ART should be assessed promptly by qualified healthcare professionals.

Storage

Store Hivus-LR in original packaging as directed on the label, protected from moisture and excessive heat, and kept out of reach of children. Do not use tablets after the expiry date printed on the pack. If your clinic provides specific storage or transport instructions, follow them carefully, especially when coordinating refills and monitoring appointments.

Why Buy from Generic Meds Mart

For patients seeking to manage HIV treatment effectively, Generic Meds Mart provides reliable access to essential antiretroviral medicines like this lopinavir and ritonavir combination in original packaging. We focus on logistics and structured access: verified packs with visible batch and expiry information, USD pricing for planning, and discreet outer packaging to support privacy. For ongoing ART supply planning, we offer global delivery options and tracking where available so patients and clinics can coordinate refills with follow-up schedules.

Generic Meds Mart does not replace your HIV clinician. Decisions about regimen choice, substitutions, and side effect management must be made by qualified healthcare professionals who know your medical history and monitoring plan.

Order Now

Before you buy generic Hivus-LR online from Generic Meds Mart, confirm with your HIV clinician that lopinavir/ritonavir 200/50 mg is appropriate within your complete ART regimen and that your monitoring plan is in place. Once your prescription-led plan is confirmed, select Hivus-LR (1 pack / 60 tabs), add it to your cart, and complete secure checkout in USD. Your order will be dispatched in discreet packaging, with delivery options designed to support continuity of care and refill planning.

Do not start, stop, or change ART medicines independently. If you develop symptoms that could indicate serious side effects, contact your HIV clinic urgently or seek emergency medical care and inform clinicians that you are taking lopinavir/ritonavir.

FAQ about Hivus-LR (Lopinavir/Ritonavir)

Q1: What is Hivus-LR used for?

Hivus-LR contains lopinavir/ritonavir and is used for HIV-1 treatment as part of a complete combination ART regimen prescribed and monitored by an HIV specialist.

Q2: Is Hivus-LR a fixed-dose combination tablet?

Yes. Hivus-LR is a fixed-dose combination tablet that includes lopinavir plus ritonavir, with ritonavir acting as a booster in protease inhibitor–based ART strategies.

Q3: Why is ritonavir included with lopinavir?

Ritonavir boosts lopinavir levels by slowing its metabolism, which helps maintain therapeutic exposure in a boosted protease inhibitor regimen designed by a specialist.

Q4: What should I do if I miss a dose?

Follow your clinic’s instructions and do not take extra doses unless your prescribing team tells you to. If you are unsure, contact your HIV clinic promptly for guidance.

Q5: What monitoring is usually needed during treatment?

Monitoring commonly includes clinical follow-up and laboratory checks such as liver tests and metabolic parameters, with frequency defined by your HIV clinician based on your ART regimen and overall risk profile.

Q6: Is Hivus-LR 200/50 mg the same as Kaletra (Generic Kaletra)?

Hivus-LR 200/50 mg is Generic Kaletra — it contains the same active ingredient (lopinavir/ritonavir) as Kaletra. It’s used for the same purpose at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), tablet appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.